Ochsner Health System: Clinical Trials

7 trials sponsored by Ochsner Health System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 7 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 3, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 22Completed 2

Follow Ochsner Health System: new trials by email

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Penicillin to Prevent Early Rheumatic Heart Disease in School-Aged Children
Oral Penicillin V - Rheumatic Heart Disease in Children
Phase 3Not yet recruitingChildren's Hospital Medical Center, Cincinnati96222027-02-012026-09-03
Regional Anesthesia in Pediatric Orthopaedic Patients
Ropivacaine - Anesthesia, Local, Anesthesia
Phase 2 / Phase 3CompletedOchsner Health System242021-06-242025-07-29
Statins In Intracerbral Hemorrhage
Statins - Intracerebral Hemorrhage
Phase 3RecruitingBeth Israel Deaconess Medical Center14562020-06-102026-04-21
Xylitol for Chronic Sinusitis
Xylitol, Saline - Chronic Rhinosinusitis, Rhinosinusitis
Phase 2 / Phase 3CompletedOchsner Health System12018-03-012023-04-07
The Role of 5-Fluorouracil in Post-Operative Scar Formation Following Direct Brow Ptosis Repair
5-Fluorouracil, Normal Saline Flush, 0.9% Injectable Solution - Brow Ptosis, Facial Scarring
Phase 3UnknownEyelid and Facial Consultants502017-05-202018-07-26
Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65
Lenalidomide, Bortezomib, Dexamethasone - Multiple Myeloma
Phase 3Active not recruitingPaul Richardson, MD7292010-09-012026-01-22
Treatment of Acute Lymphoblastic Leukemia in Children
prednisone, dexamethasone, doxorubicin - Acute Lymphoblastic Leukemia
Phase 3CompletedDana-Farber Cancer Institute4982000-09-012013-04-25

Conditions studied

Cerebral Hemorrhage (1)  ·  Multiple Myeloma (1)  ·  Musculoskeletal Diseases (1)  ·  Neoplasms, Plasma Cell (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Rheumatic Heart Disease (1)  ·  Rhinosinusitis (1)  ·  Sinusitis (1)

Interventions

Dexamethasone (2)  ·  3-hydroxy-3-methylglutaryl-coenzyme A (1)  ·  Asparaginase (1)  ·  Bortezomib (1)  ·  Calcium Dobesilate (1)  ·  Cytarabine (1)  ·  Dexrazoxane (1)  ·  Doxorubicin (1)  ·  Fluorouracil (1)  ·  Hydrocortisone (1)  ·  Hydroxymethylglutaryl-CoA Reductase Inhibitors (1)  ·  Lenalidomide (1)  ·  Leucovorin (1)  ·  Methotrexate (1)  ·  Penicillin V (1)

Countries

United States (6)  ·  Uganda (1)

Top investigators

Adham B. al Hariri, M.D. (1)  ·  Joselyn Rwebembera (1)  ·  Lewis Silverman, MD (1)  ·  Paul G. Richardson, MD (1)

Results publications

PMID 15023840, PMID 15316237, PMID 15510034, PMID 17405780, PMID 17882910, PMID 21994147, PMID 23358966, PMID 23378777, PMID 23785241, PMID 27394715, PMID 28390807, PMID 34010223, PMID 34549906, PMID 35660812, PMID 38429252, PMID 8281565, PMID 9755259